1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anesthetic Effect-Pipeline Insights, 2014

Anesthetic Effect-Pipeline Insights, 2014

  • August 2014
  • -
  • Delve Insight

SUMMARY
DelveInsight’s,“ Anesthetic Effect-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Anesthetic Effect. This report provides information on the therapeutic development based on the Anesthetic Effect dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Anesthetic Effect
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Anesthetic Effect pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Anesthetic Effect and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Anesthetic Effect
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Anesthetic Effect pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Anesthetic Effect-Pipeline Insights, 2014
Table of Contents
- Anesthetic Effect Overview
- Anesthetic Effect Pipeline Therapeutics
- Anesthetic Effect Therapeutics under Development by Companies
- Anesthetic Effect Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Anesthetic Effect Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Anesthetic Effect Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Anesthetic Effect Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Anesthetic Effect - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Anesthetic Effect - Discontinued Products
- Anesthetic Effect - Dormant Products
- Companies Involved in Therapeutics Development for Anesthetic Effect
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Anesthetic Effect, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Anesthetic Effect Assessment by Monotherapy Products
- Anesthetic Effect Assessment by Combination Products
- Anesthetic Effect Assessment by Route of Administration
- Anesthetic Effect Assessment by Stage and Route of Administration
- Anesthetic Effect Assessment by Molecule Type
- Anesthetic Effect Assessment by Stage and Molecule Type
- Anesthetic Effect Therapeutics - Discontinued Products
- Anesthetic Effect Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Anesthetic Effect, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Anesthetic Effect Assessment by Monotherapy Products
- Anesthetic Effect Assessment by Combination Products
- Anesthetic Effect Assessment by Route of Administration
- Anesthetic Effect Assessment by Stage and Route of Administration
- Anesthetic Effect Assessment by Molecule Type
- Anesthetic Effect Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Sufentanil Citrate Market: By Applications (Surgery, Epidural Anaesthesia and Medicinal Application) & By Geography (North America, Europe, Asia Pacific & Rest of the World (RoW))-Forecast (2016-2021)

Sufentanil Citrate Market: By Applications (Surgery, Epidural Anaesthesia and Medicinal Application) & By Geography (North America, Europe, Asia Pacific & Rest of the World (RoW))-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Sufentanil, also known as R30730 or brand name Sufenta, is a synthetic opioid analgesic drug which is considerably more potent than its parent drug, fentanyl, morphine. It is used for producing anesthesia ...

Global Inhalation Anesthetics Market - Growth, Trends and Forecast (2016 - 2021)

Global Inhalation Anesthetics Market - Growth, Trends and Forecast (2016 - 2021)

  • $ 4250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The global Inhalation Anesthetics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of ...

Global Local Anesthesia Drugs Market - Growth, Trends and Forecast (2016 - 2021)

Global Local Anesthesia Drugs Market - Growth, Trends and Forecast (2016 - 2021)

  • $ 4250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The global local anesthesia drugs market accounted for a market value of USD 8,160 million in 2015 and is expected to reach USD 8,335 million in 2016. The market is expected to reach USD 9,240 million ...


Download Unlimited Documents from Trusted Public Sources

Opioid Market in the US

  • November 2016
    4 pages
  • Opioid  

  • United States  

View report >

Hormone Market in the US

  • November 2016
    20 pages
  • Hormone  

  • United States  

View report >

Anesthetics Market in the UK

  • October 2016
    2 pages
  • Anesthetics  

    Opioid  

  • United Kingdom  

    Europe  

View report >

Related Market Segments :

Anesthetics

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.